LAURA LINDAUER: Open Payments
NPI 1043365109 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 17 payments from 9 companies in 2025. Trend: 2023 $264 · 2024 $230 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Novo Nordisk Inc | 2 | $32 |
| Astellas Pharma US Inc | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| Amgen Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: MOUNJARO, JARDIANCE, Veozah, FREESTYLE LIBRE 3, AIRSUPRA, EVENITY, Rybelsus, Ozempic.
Industry payments across NE — which companies pay providers there.
